{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T20:56:30Z","timestamp":1760648190872,"version":"3.44.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,8,29]]},"DOI":"10.7759\/cureus.91240","type":"journal-article","created":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T15:32:52Z","timestamp":1756481572000},"source":"Crossref","is-referenced-by-count":1,"title":["The Straw That Broke the Camel\u2019s Back: Amoxicillin-Clavulanate Unraveling Autoimmune Hepatitis in a Previously Asymptomatic Female"],"prefix":"10.7759","author":[{"given":"John A","family":"Gallagher","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yara","family":"Dababneh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Gregory","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beena U","family":"Ahsan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Humberto C","family":"Gonzalez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1177\/17562848231163410","article-title":"Drug-induced liver injury: a comprehensive review","volume":"16","author":"Hosack T","year":"2023","unstructured":"Hosack T, Damry D, Biswas S. Drug-induced liver injury: a comprehensive review. Therap Adv Gastroenterol. 2023, 16:10. 10.1177\/17562848231163410","journal-title":"Therap Adv Gastroenterol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms17020224","article-title":"Hepatotoxicity by drugs: The most common implicated agent","volume":"17","author":"Bj\u00f6rnsson ES","year":"2016","unstructured":"Bj\u00f6rnsson ES. Hepatotoxicity by drugs: The most common implicated agent. Int J Mol Sci. 2016, 17:224. 10.3390\/ijms17020224","journal-title":"Int J Mol Sci"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2013.02.006","article-title":"Incidence, presentation, and outcomes in patients with drug-induced liver injury in the general population of Iceland","volume":"144","author":"Bj\u00f6rnsson ES","year":"2013","unstructured":"Bj\u00f6rnsson ES, Bergmann OM, Bj\u00f6rnsson HK, Kvaran RB, Olafsson S. Incidence, presentation, and outcomes in patients with drug-induced liver injury in the general population of Iceland. Gastroenterology. 2013, 144:1419-25. 10.1053\/j.gastro.2013.02.006","journal-title":"Gastroenterology"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.gastro.2005.05.006","article-title":"Drug-induced liver injury: an analysis of 461 incidences submitted to the Spanish registry over a 10-year period","volume":"129","author":"Andrade RJ","year":"2005","unstructured":"Andrade RJ, Lucena MI, Fern\u00e1ndez MC, et al.. Drug-induced liver injury: an analysis of 461 incidences submitted to the Spanish registry over a 10-year period. Gastroenterology. 2005, 129:512-21. 10.1016\/j.gastro.2005.05.006","journal-title":"Gastroenterology"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-016-4121-6","article-title":"Amoxicillin-clavulanate-induced liver injury","volume":"61","author":"deLemos AS","year":"2016","unstructured":"deLemos AS, Ghabril M, Rockey DC, et al.. Amoxicillin-clavulanate-induced liver injury. Dig Dis Sci. 2016, 61:2406-16. 10.1007\/s10620-016-4121-6","journal-title":"Dig Dis Sci"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1002\/hep.31065","article-title":"Diagnosis and management of autoimmune hepatitis in adults and children: 2019 practice guidance and guidelines from the American Association for the Study of Liver Diseases","volume":"72","author":"Mack CL","year":"2020","unstructured":"Mack CL, Adams D, Assis DN, et al.. Diagnosis and management of autoimmune hepatitis in adults and children: 2019 practice guidance and guidelines from the American Association for the Study of Liver Diseases. Hepatology. 2020, 72:671-722. 10.1002\/hep.31065","journal-title":"Hepatology"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1002\/hep.23588","article-title":"Drug-induced autoimmune hepatitis: clinical characteristics and prognosis","volume":"51","author":"Bj\u00f6rnsson E","year":"2010","unstructured":"Bj\u00f6rnsson E, Talwalkar J, Treeprasertsuk S, et al.. Drug-induced autoimmune hepatitis: clinical characteristics and prognosis. Hepatology. 2010, 51:2040-8. 10.1002\/hep.23588","journal-title":"Hepatology"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1097\/MCG.0000000000001449","article-title":"Epidemiology of autoimmune hepatitis (AIH) in the United States between 2014 and 2019: a population-based national study","volume":"55","author":"Tunio NA","year":"2021","unstructured":"Tunio NA, Mansoor E, Sheriff MZ, Cooper GS, Sclair SN, Cohen SM. Epidemiology of autoimmune hepatitis (AIH) in the United States between 2014 and 2019: a population-based national study. J Clin Gastroenterol. 2021, 55:903-10. 10.1097\/MCG.0000000000001449","journal-title":"J Clin Gastroenterol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2015.06.030","article-title":"EASL Clinical Practice Guidelines: Autoimmune hepatitis","volume":"63","author":"European Association for the Study of the Liver","year":"2015","unstructured":"European Association for the Study of the Liver. EASL Clinical Practice Guidelines: Autoimmune hepatitis. J Hepatol. 2015, 63:971-1004. 10.1016\/j.jhep.2015.06.030","journal-title":"J Hepatol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2024.01.023","article-title":"Distinction of autoimmune hepatitis from drug-induced autoimmune like hepatitis: the answer lies at the interface","volume":"81","author":"Alkashash A","year":"2024","unstructured":"Alkashash A, Zhang X, Vuppalanchi R, Lammert C, Saxena R. Distinction of autoimmune hepatitis from drug-induced autoimmune like hepatitis: the answer lies at the interface. J Hepatol. 2024, 81:e45-7. 10.1016\/j.jhep.2024.01.023","journal-title":"J Hepatol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2016.05.043","article-title":"Features of autoimmune hepatitis in patients with drug-induced liver injury","volume":"15","author":"de Boer YS","year":"2017","unstructured":"de Boer YS, Kosinski AS, Urban TJ, et al.. Features of autoimmune hepatitis in patients with drug-induced liver injury. Clin Gastroenterol Hepatol. 2017, 15:103-12.e2. 10.1016\/j.cgh.2016.05.043","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2025.1564124","article-title":"The role of endoplasmic reticulum aminopeptidase ERAP2 pathogenic mutation rs1363907 in amoxicillin clavulanate-induced liver injury: a special case report","volume":"16","author":"Zhan Y","year":"2025","unstructured":"Zhan Y, Liao JM, Ye L, Zhang L, Zhang Z, Yin JY. The role of endoplasmic reticulum aminopeptidase ERAP2 pathogenic mutation rs1363907 in amoxicillin clavulanate-induced liver injury: a special case report. Front Pharmacol. 2025, 16:4. 10.3389\/fphar.2025.1564124","journal-title":"Front Pharmacol"},{"key":"ref13","article-title":"Drug induced autoimmune hepatitis by amoxicillin-clavulanate","volume":"45","author":"Bari\u015f Kuzu U","year":"2016","unstructured":"Bari\u015f Kuzu U, \u00d6zta\u015f E, Kaplan M, Suna N, Temu\u00e7in Keklik T, Akdo\u011fan M. Drug induced autoimmune hepatitis by amoxicillin-clavulanate. Iran J Public Health. 2016, 45:540-1.","journal-title":"Iran J Public Health"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/0168-8278(90)90124-A","article-title":"Criteria of drug-induced liver disorders: report of an International Consensus Meeting","volume":"11","author":"B\u00e9nichou C","year":"1990","unstructured":"B\u00e9nichou C. Criteria of drug-induced liver disorders: report of an International Consensus Meeting. J Hepatol. 1990, 11:272-6. 10.1016\/0168-8278(90)90124-A","journal-title":"J Hepatol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2019.00853","article-title":"Roussel Uclaf Causality Assessment Method for drug-induced liver injury: present and future","volume":"10","author":"Danan G","year":"2019","unstructured":"Danan G, Teschke R. Roussel Uclaf Causality Assessment Method for drug-induced liver injury: present and future. Front Pharmacol. 2019, 10:853. 10.3389\/fphar.2019.00853","journal-title":"Front Pharmacol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.5858\/arpa.2014-0214-RA","article-title":"Drug-induced liver injury","volume":"139","author":"Fisher K","year":"2015","unstructured":"Fisher K, Vuppalanchi R, Saxena R. Drug-induced liver injury. Arch Pathol Lab Med. 2015, 139:876-87. 10.5858\/arpa.2014-0214-RA","journal-title":"Arch Pathol Lab Med"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.32074\/1591-951X-241","article-title":"Pathology of autoimmune hepatitis","volume":"113","author":"Covelli C","year":"2021","unstructured":"Covelli C, Sacchi D, Sarcognato S, et al.. Pathology of autoimmune hepatitis. Pathologica. 2021, 113:185-93. 10.32074\/1591-951X-241","journal-title":"Pathologica"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1002\/hep.22322","article-title":"Simplified criteria for the diagnosis of autoimmune hepatitis","volume":"48","author":"Hennes EM","year":"2008","unstructured":"Hennes EM, Zeniya M, Czaja AJ, et al.. Simplified criteria for the diagnosis of autoimmune hepatitis. Hepatology. 2008, 48:169-76. 10.1002\/hep.22322","journal-title":"Hepatology"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/s0168-8278(99)80297-9","article-title":"International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis","volume":"31","author":"Alvarez F","year":"1999","unstructured":"Alvarez F, Berg PA, Bianchi FB, et al.. International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol. 1999, 31:929-38. 10.1016\/s0168-8278(99)80297-9","journal-title":"J Hepatol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1002\/hep.24481","article-title":"The use of liver biopsy evaluation in discrimination of idiopathic autoimmune hepatitis versus drug-induced liver injury","volume":"54","author":"Suzuki A","year":"2011","unstructured":"Suzuki A, Brunt EM, Kleiner DE, et al.. The use of liver biopsy evaluation in discrimination of idiopathic autoimmune hepatitis versus drug-induced liver injury. Hepatology. 2011, 54:931-9. 10.1002\/hep.24481","journal-title":"Hepatology"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2023.11.032","article-title":"An open-label randomised-controlled trial of azathioprine vs. mycophenolate mofetil for the induction of remission in treatment-naive autoimmune hepatitis","volume":"80","author":"Snijders RJ","year":"2024","unstructured":"Snijders RJ, Stoelinga AE, Gevers TJ, et al.. An open-label randomised-controlled trial of azathioprine vs. mycophenolate mofetil for the induction of remission in treatment-naive autoimmune hepatitis. J Hepatol. 2024, 80:576-85. 10.1016\/j.jhep.2023.11.032","journal-title":"J Hepatol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1155\/2010\/891252","article-title":"Mycophenolate mofetil for the treatment of autoimmune hepatitis in patients refractory or intolerant to conventional therapy","volume":"24","author":"Sharzehi K","year":"2010","unstructured":"Sharzehi K, Huang MA, Schreibman IR, Brown KA. Mycophenolate mofetil for the treatment of autoimmune hepatitis in patients refractory or intolerant to conventional therapy. Can J Gastroenterol. 2010, 24:588-92. 10.1155\/2010\/891252","journal-title":"Can J Gastroenterol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/392126-the-straw-that-broke-the-camels-back-amoxicillin-clavulanate-unraveling-autoimmune-hepatitis-in-a-previously-asymptomatic-female","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T15:32:53Z","timestamp":1756481573000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/392126-the-straw-that-broke-the-camels-back-amoxicillin-clavulanate-unraveling-autoimmune-hepatitis-in-a-previously-asymptomatic-female"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,29]]},"references-count":22,"URL":"https:\/\/doi.org\/10.7759\/cureus.91240","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8,29]]}}}